Scientists discover how brain regulates fat metabolism

Scientists have discovered the brain region which controls whether excess energy should be stored as fat or burned in our muscles. The researchers hope that their findings will lead to the development of new treatments for obesity. The work, which was partly funded by the EU, is published in the Journal of Clinical Investigation.

The brain region in question is the melanocortin system. It is already known that this system receives messages from the gut indicating whether it is hungry or full. The system responds by causing the body to either take in or burn calories.

This latest piece of research reveals that the melanocortin system is also responsible for controlling whether extra energy should be converted to fat and whether it should be stored or metabolised.

Experiments in rats showed that when the system is stimulated to increase activity, fat is metabolised. When activity levels in the system are reduced, fat accumulation increases. All of this happens independently of levels of food intake.

"We were able, in essence, to change traffic signals in so-called nutrient highways in the body so that calories were metabolised, and not dumped into fat cells, and we did this without changing the rate of food intake," explains Matthias Tschöp, Associate Professor of Psychiatry at the University of Cincinnati, who led the research.

The team also studied people who suffer from obesity caused by a genetic defect in the melanocortin system. The results indicated that the problem was caused by a fault in the fat storage/burning mechanism.

"Our results do not just explain why reduced levels of melanocortin can lead to overweight, even without increased food intake, but they indicate new targets for the development of effective medicines for controlling overweight," said Professor Tschöp. "These are urgently needed if we are to overcome the problem of obesity which is growing around the world."

EU funding for the work came from the Sixth Framework Programme DIABESITY project, which is looking for novel molecular targets for obesity and type 2 diabetes. Earlier this year, researchers from the project identified a molecule which contributes to obesity by providing the link between spontaneous physical activity, such as fidgeting whilst working at a computer, and food intake.

For further information, please visit www.jci.org

Copyright ©European Communities, 2007
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Salvat Laboratories announces submission of New Dr…

Salvat Laboratories announced that it has submitted a New Drug Application (NDA) to the FDA for the approval of the first ocular corticosteroid formulated in a nanoemulsi...

Pfizer's elranatamab granted FDA Breakthrough Ther…

Pfizer Inc. (NYSE:PFE) announced its investigational cancer immunotherapy, elranatamab, received Breakthrough Therapy Designation from the U.S. Food and Drug Administrati...

New insights on antibody responses to Omicron vari…

Knowing how well vaccination against one SARS-CoV-2 strain (with or without previous infection) counteracts infection with a different strain is a critical research quest...

Ancient viral DNA in human genome guards against i…

Viral DNA in human genomes, embedded there from ancient infections, serve as antivirals that protect human cells against certain present-day viruses, according to new res...

The origin-of-life molecule, a key to cancer resea…

RNA, the molecule that gave rise to life, has been shown to be essential for repairing human genetic material and preventing mutations that might lead to developing cance...

Bayer with continued strong performance

The Bayer Group maintained its strong business performance across all three divisions in the third quarter. "Despite rising inflation and global supply chain problems, we...

Sugar molecules as a target in cancer therapy

Cancer cells use sugar molecules on their surface to disable attacks by the body's immune system. Researchers at the University of Basel now report on how this mechanism ...

Vividion Therapeutics names Jenna Goldberg as Chie…

Vividion Therapeutics, Inc., a biopharmaceutical company utilizing novel discovery technologies to unlock high value, traditionally undruggable targets with precision the...

COVID vaccination improves effectiveness of cancer…

Patients with nasopharyngeal cancer are often treated with drugs that activate their immune system against the tumor. Until now, it was feared that vaccination against Co...

Making melanoma immortal: Pitt scientists discover…

Scientists at the University of Pittsburgh School of Medicine have discovered the missing puzzle piece in the mystery of how melanoma tumors control their mortality. I...

Pfizer and BioNTech receive positive CHMP opinion …

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced a booster dose of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine (COMIRNATY® Original/Omicron ...

Study reveals vaccine confidence declined consider…

A new study suggests that, despite the success of the COVID-19 vaccination campaigns, vaccine confidence has declined significantly since the start of the pandemic. Re...